In-market Utilisation of Liraglutide Used for Weight Management in Europe

NCT02967757 · Completed

Last updated 2026-05-28

This study examined how liraglutide, a medication used for weight management, is prescribed and used in real-world settings among adults with obesity in Europe.

Status Completed The study has finished.

Type Observational

Participants 316 people

Who can join all sexes

Timeline Started 2016-12 · est. completion 2019-05

Where 19 sites · Germany, Italy

What this study is testing ClinicalTrials.gov NCT02967757 ↗

Description as written by the study sponsor.

This study is conducted in Europe. The aim of this study is to investigate usage of liraglutide for weight management in clinical practice.

Treatments tested

liraglutide Drug

Patients will be treated according to routine clinical practice at the discretion of the treating physician. The study will gather data over the course of routine treatment for liraglutide 3.0 mg and liraglutide 1.2 mg/1.8 mg treated patients

Main thing measured	Number of patients with BMI above or equal to 30 kg/m^2
Sponsor	Novo Nordisk A/S
Conditions studied	Metabolism and Nutrition Disorder, Obesity
GLP-1 drugs	liraglutide

Full protocol, eligibility, and contacts on ClinicalTrials.gov NCT02967757 ↗